Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7236
Peer-review started: April 26, 2016
First decision: May 30, 2016
Revised: June 28, 2016
Accepted: August 1, 2016
Article in press: August 1, 2016
Published online: August 28, 2016
Core tip: Non-alcoholic fatty liver disease (NAFLD) patients are at risk of NAFLD-related cirrhosis and hepatocellular carcinoma, particularly in the setting of liver fibrosis with concurrent metabolic syndrome. Transient elastography (TE) with controlled attenuation parameter (CAP) is a fast, reliable, repeatable non-invasive method for the assessment of liver steatosis and fibrosis. TE with CAP may be used to diagnose and monitor patients with NAFLD. TE with CAP is a favorable means of excluding advanced fibrosis.